RM
Rajiv Malik
About Rajiv Malik
Data last updated:
Rajiv Malik is a Director at Mylan Laboratories Limited (since 2005), Nominee Director at Rapidue Technologies Private Limited (since 2025) and Director at Biocon Limited (since 2026), and holds 1 more current directorship. The companies operate in Pharma, Information Technology and Financial Services. The 2 current companies with reported revenue have a combined latest revenue of ₹8,489 Cr; the largest is Mylan Laboratories Limited at ₹7,504 Cr (FY 2025). Earlier, Rajiv Malik was a Nominee Director at Biocon Biologics Limited (2022–2026) and Director at Axis Finvest Advisory Private Limited (2006–2008) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Mylan Laboratories Limited U24231TG1984PLC005146 | Director | 28 Jul 2005 | 1984 | ₹7,504 Cr (FY 2025) | Active |
 Rapidue Technologies Private Limited U38220TG2015PTC101913 | Nominee Director | 27 Mar 2025 | 2015 | ₹985 Cr (FY 2025) | Active |
 Biocon Limited L24234KA1978PLC003417 | Director | 01 Aug 2026 | 1978 | Active | |
| Gurujee Consulting Llp ACT-4360 | Designated Partner | 12 Dec 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Biocon Biologics Limited U24119KA2016PLC093936 | Nominee Director | 29 Nov 2022 | 2016 | ₹10,144 Cr (FY 2025) | Active |
 Axis Finvest Advisory Private Limited U74999MH2006PTC161204 | Director | 20 Jun 2006 | 2006 | Converted To Llp | |
 Concord Biotech Limited L24230GJ1984PLC007440 | Director | 24 Mar 2007 | 1984 | ₹888 Cr (FY 2023) | Active |
 Mylan Pharmaceuticals Private Limited U73100TG1997PTC149781 | Additional Director | 01 Oct 2007 | 1997 | ₹1,253 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rajiv Malik
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajiv Malik
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajiv Malik
Rajiv Malik currently holds 4 directorships: Mylan Laboratories Limited (Director, since 28 Jul 2005, revenue ₹7,504 Cr (FY 2025)); Rapidue Technologies Private Limited (Nominee Director, since 27 Mar 2025, revenue ₹985 Cr (FY 2025)); Biocon Limited (Director, since 01 Aug 2026); Gurujee Consulting Llp (Designated Partner, since 12 Dec 2025).
Rajiv Malik was first appointed on 28 Jul 2005 as Director at Mylan Laboratories Limited. The most recent appointment on record is 01 Aug 2026 at Biocon Limited.
The 2 current companies of Rajiv Malik that report revenue have a combined latest revenue of ₹8,489 Cr: Mylan Laboratories Limited ₹7,504 Cr (FY 2025); Rapidue Technologies Private Limited ₹985 Cr (FY 2025).
Rajiv Malik held 4 earlier board appointments: Biocon Biologics Limited (Nominee Director, 29 Nov 2022 to 21 Jan 2026); Axis Finvest Advisory Private Limited (Director, 20 Jun 2006 to 03 Apr 2008); Concord Biotech Limited (Director, 24 Mar 2007 to 04 Dec 2009); Mylan Pharmaceuticals Private Limited (Additional Director, 01 Oct 2007 to 28 Mar 2008).
The current boards of Rajiv Malik's companies include Akshay Nanda (Mylan Laboratories Limited), Arvind Shankar Kanda (Mylan Laboratories Limited), Nagaraj Goud Bodige (Mylan Laboratories Limited), Nagaraj Goud Bodige (Mylan Laboratories Limited), Ramya Suresh (Mylan Laboratories Limited), Sarada Kalyani Bhagawati (Mylan Laboratories Limited), among others.